Table 1.
Variable (n = 158) | Total |
---|---|
Age (mean ± SD) | 59.5 ± 14.0 |
Min-Max | 20–88 |
Stage of life | n (%) |
Adult | 69 (43.7) |
Elderly | 89 (56.3) |
Gender | |
Male | 81 (51.3) |
Female | 77 (48.7) |
Color | |
Non-white | 93 (58.9) |
White | 65 (41.1) |
Tumor Location | |
Lower GIT | 53 (33.5) |
Attached glands | 39 (24.7) |
Upper GIT | 27 (17.1) |
Othersa | 39 (24.7) |
Length of hospital stay | |
≤ 7 days | 86 (54,4) |
> 7 days | 72 (45,6) |
PG-SGA | |
Well nourished (A) | 64 (40.5) |
Moderately malnourished (B) | 64 (40.5) |
Severely malnourished (C) | 30 (19.0) |
Presence of Cachexia | |
Yes | 57 (36.1) |
No | 101 (63.9) |
Dynapenia | |
Yes | 37 (23.4) |
No | 121 (76.6) |
aOthers (corresponding to cancers with a low prevalence within the sample): 6.33%: lung and thorax cancer; 3.80%: hematological cancer; 3.16%: skin cancer; 1.89%: cancer of unknown behavior; 1.26%: ovarian cancer; 0.63%: stromal gastrointestinal cancer; 0.63%: bladder cancer; 0.63%: cervical cancer; 0.63%: ganglion cancer; 0.63%: parotid gland cancer; 0.63%: breast cancer; 0.63%: mediastinal cancer; 0.63%: cancer from other locations; 0.63%: peritoneum cancer; 0.63%: pleural cancer; 0.63%: connective tissue cancer; 0.63%: thyroid cancer; 0.63%: submandibular cancer. PG-SGA: Patient-Generated Subjective Global Assessment